Background: Both Helicobacter pylori-infected peptic ulcer disease (PUD) and depression are common in older adults. Although H. helicobacter eradication has significantly reduced the risk of PUD recurrence, it remains unknown whether such therapy achieves comparable effect among older patients with and without depression.
Introduction
Depression is a stress-related mood disorder with a chronic course of emotional dysregulation and depressive cognition 1 that affects approximately 14.3% of the total global older population 2 . Peptic ulcer disease (PUD) is defined as peptic injury of the digestive tract that leads to mucosal break reaching the submucosa, which usually occurs in the stomach and/or proximal duodenum 3 . Although the role of psychological factors in PUD formation and relapse has generally been ignored 4 , recent clinical evidence revealed that depression may contribute to PUD through disturbing hypothalamic-pituitary-adrenal (HPA) axis and dysregulating corticosterone, which is ulcerogenic under continuous and prolonged stress 5 . Likewise, empirical studies have also reported that individuals with depression are at a higher risk of PUD [6] [7] [8] and infection of helicobacter pylori (H. pylori) 9 , which is a gram-negative bacterial pathogen associated with various gastroduodenal complications such as chronic gastritis, intestinal metaplasia, gastric cancer, and PUD 3 . H. pylori infection was found to increase with age, plausibly due to the poor sanitary and socioeconomic conditions of this age cohort 10 . Recent literature suggests that H. pylori is present in over 70% of the older patients with PUD 11 and is linked to an elevated risk of PUD recurrence 12 . Clinical trials further indicated that rate of PUD recurrence among H. pyloriassociated PUD patients following H. pylori eradication therapy ranged from 5 to 20% 10, 13, 14 , in comparison to the rate of over 50% documented in non-eradicated patients 15 . Nevertheless, recent evidence that only reliance on H. pylori eradication therapy was insufficient to prevent PUD recurrence 13 implies the possibility of co-factors and alternative pathways underlying this process. Although depression has been rated as a potential contributor to PUD, it remains unknown whether it also plays a part in PUD recurrence or whether H. pylori eradication therapy achieves comparable effect on PUD recurrence among depressed and non-depressed older patients.
There are other behavioral and clinical variables that may also influence PUD recurrence. Polyphenols from green tea, a widely consumed beverage in East Asia, has been found to not only accelerate ulcer healing but also provide gastroprotection against various ulcerogens 16 . Alcohol and cigarette consumption is a common way of self-medication among patients with depression 8 . Although some studies reported abnormal mucosal barriers and PUD recurrence associated with such substance use, these results were not replicated in other studies 13, 17 . Among clinical variables, Nonsteroidal Antiinflammatory Drugs (NSAIDs) and aspirin were identified to enhance the risk of PUD and its recurrence 18 by inhibiting cyclooxygenase1 (COX-1)-derived prostaglandin synthesis and damaging gastroduodenal mucosa 3, 19 . Acetaminophen is therefore often prescribed as an alternative analgesic to many indications, as its analgesic and antipyretic actions resemble those of NSAIDs and aspirin. However, the effect of acetaminophen on PUD recurrence has not been reported.
Despite an elevated susceptibility of older adults to gastroduodenal diseases such as PUD in older adults and their detrimental impact on this population, there is lack of empirical data analyzing this geriatric issue in exiting literature. In view of a growing older population worldwide and the high risk of PUD complications such as hemorrhage, perforation, and mortality in older patients, new empirical data are urgently needed to address this biopsychosocial health problem. This study therefore aims to identify the prospective association between depression and PUD recurrence while considering an array of behavioral and clinical confounders. Specifically, this study hypothesized that clinical diagnosis of and self-reports of depression will have a positive impact on subsequent PUD recurrence in older patients.
Methods
Older patients aged 50 or above with H. pylori-infected gastric and/ or duodenal ulcer were included in baseline study. Older patients with cognitive impairment, malignant tumors, cardiovascular disease, impaired kidney or liver functioning, previous H. pylori-eradication treatment, previous gastric and duodenal operation, Zollinger-Ellison syndrome and who had received anti-ulcer treatment (acid inhibitors: H2-receptor antagonists, proton pump inhibitors; mucosal protective drugs: sucralfate, bismuth salt antibiotics) over the past three months were excluded.
Baseline
This study was a prospective and comparative trial. A gastroenterologist from each selected hospitals with equivalent education background and experiences conducted all endoscopic examinations, using the same type of endoscope (GIF-XQ260, Olympus Optical Co., Ltd, Tokyo, Japan). Positive H. pylori infection was determined by positive rapid urease test (Ballard Medical Products, Draper, UT, U.S.A.) and results of histological examination. Severities of inflammation were examined using the Sydney System 21 . Of the 1,425 older patients meeting recruitment criteria, 996 gave informed consent after being briefed on the study purpose and confidentiality issues. A 10-day antipylori treatment with esomeprazole 20 mg bid (two time per day) + amoxicillin 1000 mg bid + clarithromycin 500 mg bid was performed on the patients enrolled at baseline (n = 1,172). Subsequently, a 4-week anti-ulcer therapy with omeprazole 20 mg bid was given. Confirmation test was conducted 4 weeks after discontinuation of antiulcer therapy, to avoid false-negative results. Negative results on rapid urease test were considered as successful eradication of H. pylori. Healed ulcers were confirmed using histological examination. Detailed description for the performance of endoscopic examination and RUT test can be found elsewhere 22 .
Follow-up
A total of 1,056 older patients with H. pylori eradicated and peptic ulcer healed by the end of 2014 were included in the follow-up study. Four weeks after the eradication of H. pylori and healing of PUD, these patients were followed every six months for 3 years. During follow-up period, patients who ingested anti-ulcer medications for ≥ 3 days were excluded (n= 79). Description of the sample flow for this study can be found in Figure 1 . During follow-up period, peptic ulcer symptoms, such as burning stomach pain, bloating, feeling of fullness, dyspepsia, acid reflux, nausea, and heartburn, were documented at each visits. All the patients who were included in the follow-up study were checked for H. pylori reinfection and PUD recurrence at six months intervals, using different methods depending on the presence and absence of PUD symptoms. All the patients with these symptoms persisting for over a week were instructed to have an endoscopic examination together with rapid urease test and pathological examination to determine recurrence of peptic ulcer and reinfection of H. pylori. In particular, pathological analysis served as the validation check in addition to RUT and only patients who were screened negative for both RUT and pathological analysis were considered as being free from H. pylori reinfection. Those without these symptoms were given Carbon13-labelled urea breath test (Carbon13-UBT) to determine H. pylori reinfection. Based on previous experience, a sample size of 858 was required to achieve a statistical power of 0.9 to detect an effect size of 0.2 at a probability level of 0.05. This study was approved by the ethics committee of the authors' affiliated institution.
Measurements

Outcome variable
The outcome variable was recurrent PUD.
Major independent variable
We included as the major independent variable only depression with the first onset prior to the end point, which is the date of PUD recurrence, failure to follow-up, death, or the end of 2017. Self-reported depression was measured using the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) 22 . A cut-off score of ≥ 8 was a clinical threshold to define depression 22 . The HADS-D achieved an internal consistency α of 0.665 in this study. Information regarding clinical diagnosis of depression was obtained from the patients' medical records. Diagnosis of depression was made by geriatric psychiatrists based on Hamilton Depression Rating Scale, where a score of ≥ was considered having a clinical diagnosis of depression 23 . Data of diagnosis and selfreports of depression were collected at baseline.
Confounding variables
Medication history included ingestion of NSAIDs, acetaminophen, and aspirin within 6 months before the end-point. The amount and duration of ingestion of these medications were grouped into three categories, including often (>1 tablet/day for ≥7 days or >1 tablet/2 day for ≥ 14 days), occasionally (1 tablet/day for 3-7 days), and seldom (≤1 tablet/day for ≤3 days). Positive cigarette smoking was defined as ≥ 20 cigarettes/ week. Statuses of alcohol consumption was classified into nil, moderate (≤ 175g/week for men and ≤105g for women), and excessive (>175g/week for men and >105g/week for women) 24 Green tea leaves consumption was categorized into nil, low (1-100g/month), moderate (101-200g/month), moderatehigh (201-300g/month), and high (>300g/month).
Analytic plan
SPSS was used for data analysis. Prevalence (%) and mean (SDs) were assessed for major categorical and continuous variables respectively. Rates of peptic ulcer recurrence and H. pylori reinfection were recorded. In addition, a series of logistic regression models were applied with peptic ulcer recurrence as outcome variable and selfreported depression as the major independent variable. The core model (Model 1) was adjusted for age and gender.
H. pylori reinfection (biological factor) was included in Model 2. Behavioral factors as such cigarette smoking, alcohol consumption, and tea drinking were added into Model 3, and medication types (NSAIDs, acetaminophen, and aspirin) and frequency (often, occasionally, and seldom) in Block 4. All above models were repeated using diagnosed depression as the major independent variable. Multicollinearity diagnoses were performed prior to conducting logistic regression.
Results
Between January 2012 to October 2014, a total of 1589 
Sample characteristics
The majority of patients at follow-up were male (52.5%, N = 513), with a mean age of 63.57 years (SD = 9.86). No significant differences were observed in terms of age, gender, previous ulcer locations, and tea consumption in patients with and without depression. Compared to others, patients who reported depression were more likely to have H. pylori reinfection (χ 2 = 9.819, p ˂ .01), consume acetaminophen (χ 2 = 7.715, p ˂ .05), NSAIDs (χ 2 = 7.411, p ˂ .05), aspirin (χ 2 = 4.582, p ˂ .05), cigarette (χ 2 = 4.887, p ˂ .05), and alcohol (χ 2 = 4.238, p ˂ .05). Patients with diagnosed depression had a higher risk of H. pylori reinfection (χ 2 = 12.658, p ˂ .001). They were also more prone to consuming acetaminophen (χ 2 = 7.078, p ˂ .01), NSAIDs (χ 2 = 6.958, p ˂ .05), and aspirin (χ 2 = 4.582, p ˂ .05), cigarette (χ 2 = 5.018, p ˂ .05), and alcohol (χ 2 = 4.889, p ˂ .05).
Depression and PUD recurrence
During follow-up period, 108 patients presented peptic ulcer symptoms, including stomach pain (N = 38), feeling of fullness or bloating (N = 30), dyspepsia (N = 21), acid reflux (N = 10), nausea (N = 6), and heartburn (N = 3). These patients were referred for endoscopic examination and 70 were found recurrent PUD. However, no significant differences were found in locations, numbers, sizes, and bleeding of the recurrent ulcer (s) between patients with and without depression. Regarding peptic ulcer recurrence, the entire sample yields an overall cumulative ulcer recurrence rate of 7.2% in during the 36-month follow-up period, with an annual rate of 2.4%. Specifically, 36-month cumulative recurrence rate was significantly higher in patients with self-reported depression (10.9%) than in their counterparts free from depression (6.2%), generating annual recurrence rates of 3.63% versus 2.07%. Using clinical diagnosis to define depression, depressed patients (16.1%) were also significantly more vulnerable to ulcer recurrence than the non-depressed cohort (5.0%), with annual recurrence rates of 5.37% versus 1.67%. Multivariate logistic regression further identified that patients with diagnosed (OR 2.287 (1.198, 5.062) were over two times more likely to have recurrent peptic ulcer than their non-depressed counterparts, after adjusting for clinical and psychosocial variables. Similarly, self-reported depression was also associated with an increased odd of PUD recurrence (OR 2.418 (1.232, 4.989) . To further verify result regarding the association between self-reported depression and PUD recurrence, we have repeated the analysis by using self-reported depression as a continuous variable. The result consistently showed that a greater severity of self-reported depression increased the risk of PUD recurrence (OR 2.086 (1.183, 4.628) ).
Confounders and PUD recurrence
In the fully adjusted model ( 
Discussion
This is the first longitudinal study that examined rate and psychological risk factor of PUD recurrence in H. pyloriinfected ulcer older patients who had obtained successful H. pylori eradication. A 10-day course of proton pump inhibitor-based triple therapy and a 4-week anti-ulcer therapy were used and 91.4% of the patients enrolled had H. pylori eradicated and PUD healed, which is comparable to Total Depression (self-reports)
Non-depression (self-reports) T test/ χ 2 (p) Depression (diagnosis)
Non-depression (diagnosis) T test/ χ 2 (p)
Peptic ulcer recurrence 70 ( 13 . This study yields an overall cumulative PUD recurrence rate of 7.2% for the entire sample with successful H. pylori eradication over the 36-month followup period, giving an annual rate of 2.4%, which is higher than the annual rate of 1.9% documented in a Japanese cohort followed for four years 14 , but lower than that based on a 2-year study of a clinical sample in Taiwan (5.49%) 13 . Discrepancy in recurrence rates across studies is possibly attributed to methodological variation (i.e. length of observation period, sampling, and patient selection).
More specifically, our data suggest higher 36-month recurrence rates in patients who reported depressive symptoms (10.9%) and who had a clinical diagnosis of depression (16.1%). Our results further showed that depression (both self-reported and diagnosed) was associated with over 2-fold increased risk of PUD recurrence after adjusting for biological, clinical, behavioral, and demographic confounders, which implies that H. pylori eradication might have weaker protective effect against PUD recurrence in depressed than in nondepressed patients. Despite the lack of existing data investigating the association between depression and PUD recurrence, previous observations have shown a significant increase in the incidence of PUD 6 and gastric acid secretion 5 among patients with depression and those without. It is hypothesized that the mechanism connecting depression with peptic ulcer is associated with dysregulation of the hypothalamic-pituitary-adrenal
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(HPA) axis and sympathoadrenal stress response pathways which is linked to depression 25 . HPA dysregulation has also been identified to negatively affect gastroduodenal function, acid secretions, and immune system function [26] [27] , potentially increasing biological susceptibility to ulceration, and impairing defense against causative agents, such as H. pylori reinfection 27 . Alternatively possible is that depression may elevate the level of cortisol, which is ulcerogenic under stressful circumstances 28 . Furthermore, patients with depression are more likely to digest selective serotonin reuptake inhibitors (SSIR), which has been supported by clinical evidence to deplete serotonin from platelets, potentially leading to lowered serotonin concentration inside the platelets, impaired haemostatic function 29 , delayed plug formation, and inhibition of ulcers healing by the lack of vascular endothelial growth factor 30 .
Strengths
Our study advances previous research in three aspects. First, this study utilizes prospective data and only included as predictor depression that had first onset prior to PUD recurrence suggesting that depression may be a predictor of PUD recurrence, although future studies with more rigorous experimental design are needed to verify this relationship. Second, depression in this study was based not only on clinicians' diagnosis but also self-reports, which allows for identifying patients with depressive symptoms but had not visited psychological clinics. Third, PUD diagnosis in this study was obtained from endoscopic findings, which provided more reliable and valid results than those solely depending on patients' subjective complaints 6 .
Limitations
Limitations should be noted. First, for economic consideration, endoscopic examination was only performed for patients with possible PUD symptoms rather than all studied patients, which may underestimate PUD recurrence rate. Second, this study did not analyze the effect of concurrent use of NSAIDs, aspirin, and acetaminophen, which might produce additive gastrointestinal toxicity. Third, due to the lack of experimental design, no causal relationship can be confirmed between various predictors and PUD recurrence. In addition, convenience sampling means that the present findings cannot be generalized to other older population. Furthermore, certain potential confounders, such as stressful events, personality trait, family history, or socioeconomic statuses were not included in model testing, as they are unavailable in our database. Finally, although we have speculated that HPA axis may have played a role in the relationship between depression and PUD recurrence, we were not able to further test the effect of dysregulation of HPA axis at this stage, due to the lack of relevant measure in our dataset.
Implication
This study delineates a prospective and robust relationship between depression, which suggests that endoscopic examination should be included as a routine procedure for depressed patients with previous H. pyloriinfected PUD. Psychosocial therapies targeting at depression might also help reduce the odds of PUD recurrence. Identification of other significant predictors means that PUD recurrence is a complex phenomenon attributed to multifaceted factors. Our results that frequent rather than infrequent use of NSAIDs and acetaminophen increased the risk of PUD recurrence implies that physicians should adopt risk-minimizing strategies to evaluate benefits and harms of these drugs and take special precaution when prescribing them to older patients with previous PUD. The predictive effect of aspirin on PUD recurrence suggests that older patients with previous ulcer should avoid aspirin unless under unusual circumstances and rigorous medical supervision. A lowest dose for the shortest period of time might help alleviate some related toxicity. The contradictory effect of alcohol and tea depending on different dosage suggests that these beverages, if consumed with appropriate dosage, may be a convenient and inexpensive way for primary prevention of PUD recurrence.
Conclusion
This study depends on 3-year longitudinal data to investigate the relationship between depression and PUD recurrence in older patients. Specifically, depression based on self-reports and clinical diagnosis, was found to have a longitudinal impact on subsequent recurrence of PUD. These results, if further replicated in population-based studies, will lead to a new pathway for prevention of PUD recurrence.
